Decreased incidence of graft-versus-host disease in bone marrow transplantation recipients treated with a combination of cyclosporine and methotrexate.
Tollemar
J
J
Department of Transplantation Surgery, Karolinska Institute, Huddinge Hospital, Stockholm, Sweden.
Ringdén
O
O
Sundberg
B
B
Bolme
P
P
Brattström
C
C
Gahrton
G
G
Johansen
L
L
Lönnqvist
B
B
D003524:Cyclosporins / Q000008:administration & dosage / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D006085:Graft Survival; D006086:Graft vs Host Disease / Q000453:epidemiology / Q000517:prevention & control*; D006648:Histocompatibility; D006801:Humans; D008727:Methotrexate / Q000008:administration & dosage / Q000627:therapeutic use*; D011300:Preoperative Care; D013548:Sweden
D003524:Cyclosporins; D008727:Methotrexate